Novel MRE Technique to Assess a Risk Factor for Liver Cancer
NCT05165446 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 35
Last updated 2026-04-23
Summary
The aim of this proposal is to investigate a novel imaging method to identify patients with non-alcoholic steatohepatitis (NASH) who are at risk for hepatocellular carcinoma (HCC).
Conditions
- NASH - Nonalcoholic Steatohepatitis
Sponsors & Collaborators
-
Natalie Torok
lead OTHER
Principal Investigators
-
Natalie Torok, MD · Stanford University
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-01-27
- Primary Completion
- 2024-01-01
- Completion
- 2026-08-30
Countries
- United States
Study Locations
More Related Trials
-
Viscoelasticity Imaging to Assess Liver Cancer
NCT04409340 ·Status: UNKNOWN
-
Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis
NCT04288323 ·Status: COMPLETED ·Phase: PHASE4
-
Electromagnetic Tracking and Optical Imaging With ICG for Hepatic Biopsies
NCT04258566 ·Status: TERMINATED ·Phase: NA
-
Non-invasive Quantification of Liver Iron With MRI
NCT01516853 ·Status: COMPLETED
-
Magnetic Resonance Elastography for Assessment of Liver Fibrosis (MK-0000-132)(COMPLETED)
NCT00896233 ·Status: COMPLETED ·Phase: PHASE1
-
Prediction of Incidence of Liver Cancer by Use of Real-time Tissue Elastography
NCT01360892 ·Status: UNKNOWN
-
Risk Factors and Molecular Genomics of U.S. Patients With Chronic Liver Disease and Hepatocellular Cancer
NCT01034865 ·Status: COMPLETED
-
Hepatic Arteriography in Liver Cancer Diagnosis and Staging Applications
NCT02936856 ·Status: UNKNOWN ·Phase: NA
-
Noninvasive Staging of Liver Fibrosis: MR vs Ultrasound
NCT02044523 ·Status: COMPLETED
-
Improving Hepatocellular Carcinoma Screening
NCT05828446 ·Status: RECRUITING ·Phase: NA
-
T1rho Imaging of Liver in Presence of Iron
NCT05154643 ·Status: COMPLETED
-
Usefulness of Non-contrast MagnetIc Resonance imAging Versus Non-Contrast Ultrasonography for surveiLlancE of HepatoCellular Carcinoma [MIRACLE-HCC]
NCT02514434 ·Status: UNKNOWN ·Phase: NA
-
Dynamic Contrast-enhanced Magnetic Resonance Imaging in Evaluation of Liver Functional Status and Treatment Efficacy in Patients With Hepatocellular Carcinoma After Locoregional Therapy
NCT01281683 ·Status: UNKNOWN
-
The Sonic Incytes Liver Incytes System, Evaluation of Liver Fibrosis and Steatosis Versus MRE and MRI PDFF
NCT04682600 ·Status: UNKNOWN ·Phase: NA
-
By Developing a Radiomics Model to Predict the Prognosis of Patients With Hepatocellular Carcinoma After Microwave Ablation
NCT03880721 ·Status: UNKNOWN
-
Detection of Liver Fibrosis With Magnetic Resonance Imaging (MRI)
NCT01600105 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Liver Cancer With Magnetic Resonance Imaging (MRI)
NCT01871545 ·Status: COMPLETED ·Phase: NA
-
Comparison of Biannual Ultrasonography and Annual Unenhanced Magnetic Resonance Imaging for HCC Surveillance
NCT02854241 ·Status: UNKNOWN ·Phase: NA
-
Combi-elastography Assessment of HCC Recurrence After Thermal Ablation Multi-center Study
NCT04640363 ·Status: UNKNOWN
-
Multiparametric MR for Rapid Imaging Assessment of the Liver
NCT01543646 ·Status: UNKNOWN
-
Three-Dimensional T1rho Using Spiral Fast Spin Echo
NCT05154656 ·Status: WITHDRAWN
-
Abbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative Treatment
NCT06537193 ·Status: RECRUITING ·Phase: NA
-
Risk Prediction of Bleeding in Liver Cirrhosis by Combi-elastography
NCT04640350 ·Status: UNKNOWN
-
Rapid 10-Minute Liver MRI Protocol in Patients With Suspected Hepatocellular Carcinoma
NCT01390194 ·Status: COMPLETED
-
Assessment of Liver FIBROsis by Real-time Tissue ELASTography in Chronic Liver Disease
NCT01360879 ·Status: UNKNOWN